This is a National Phase entry of International Application No. PCT/AU2015/050314, filed Jun. 5, 2015, the disclosure of which is incorporated herein by reference in its entirety.
Described embodiments generally relate to nasal dilators for facilitating respiration. Some embodiments relate to a nasal dilator having a dual dilation mechanism configured to perform dual or concurrent dilation of the nostril of the user. Some embodiments relate to a nasal dilator having a valve mechanism to allow control of inhalation and exhalation through the nose. Some embodiments relate to a nasal dilator having a filtration mechanism to filter airflow during respiration.
Nasal dilator devices are typically worn by users to dilate their nasal cavities when sleeping and/or partaking in sporting activities to thereby facilitate respiration.
It is desired to address or ameliorate one or more shortcomings of known nasal dilator devices, or to at least provide a useful alternative thereto.
Throughout this specification the word “comprise”, or variations such as “comprises” or “comprising”, will be understood to imply the inclusion of a stated element, integer or step, or group of elements, integers or steps, but not the exclusion of any other element, integer or step, or group of elements, integers or steps.
Any discussion of documents, acts, materials, devices, articles or the like which has been included in the present specification is not to be taken as an admission that any or all of these matters form part of the prior art base or were common general knowledge in the field relevant to the present disclosure as it existed before the priority date of each claim of this application.
Some embodiments relate to a nasal dilator comprising a body for insertion into a nasal cavity of a nose, the body including: a loop structure having an inner surface, a reverse outer surface, a first side and a second side opposite to the first side, wherein the inner surface defines an aperture and the reverse outer surface is configured for urging against a nasal passage wall of the nose; and an arm member having a first end coupled to the loop structure and a free end, the arm member extending outwardly from the loop structure and configured to extend along a nasal passage of the nasal cavity and engage with an internal surface of a nostril of the nose.
In some embodiments, the nasal dilator may further comprise a leg member extending outwardly from the loop structure and configured to protrude from the nasal cavity of the user. For example, the arm member may extend from the first side of the loop structure and the leg member may extend from the second side of the loop structure.
In some embodiments, the loop structure may comprise an adjustment mechanism to allow for selective expansion and contraction of the loop structure. The adjustment mechanism may comprise a pin and a socket arranged to receive and engage the pin. For example, the pin and socket may extend from the inner surface of the loop structure toward each other and are configured to engage with one another to allow the adjustment mechanism to span the aperture defined by the loop structure. Alternatively, or in addition, a first length of the loop structure may comprise the pin and a second length of the loop structure may comprise the socket. In some embodiments, the adjustment mechanism may comprise a belt and a sleeve arranged to receive and engage the belt, the belt extending from a first end of the loop structure into the sleeve provided at a second end of the loop structure.
The body may comprise a platform spanning the aperture defined by the inner surface of the loop structure. The platform may be releasably coupled to the inner surface of the loop structure. In some embodiments, the platform may comprise a filter.
In some embodiments, the nasal dilator comprises a valve mechanism for controlling fluid flow through the aperture which may include a seal supported by the platform and configured to span the aperture defined by the inner surface of the loop structure. For example, the seal may include a flap configured to transition between an open state, whereby fluid may be conveyed through the platform, and a closed state, whereby fluid may be hindered from being conveyed through the platform by the flap and wherein an orifice may be disposed in the seal. Alternatively, the seal may include a ball valve configured to transition between an open state, whereby fluid may be conveyed through the platform, and a closed state, whereby fluid may be hindered from being conveyed through the platform by the ball valve and wherein an orifice may be disposed in the seal. In some embodiments, the valve mechanism may comprise a collar extending from the second side of the loop structure and forming a seal with the loop structure.
In some embodiments, the arm member may be moveably coupled to the loop structure to allow selective positioning of the arm member. For example, the arm member may be rotatably coupled or hingedly coupled to the loop structure to allow selective positioning of the arm member. In some embodiments, the arm member may comprise a ball and socket joint to couple the arm member to the loop structure. The arm member may comprise a nostril engaging element at the free end to engage with the internal surface of the nostril. The nostril engaging element may comprise a series of protrusions disposed on the nostril engaging element.
In some embodiments, the loop structure may comprise a chamber arranged to receive at least one of a compound and a medicament. In some embodiments, the loop structure may comprise an outer layer disposed along at least a portion of the outer surface of the loop structure. The outer layer may be or comprise a deformable material. The deformable material may comprise at least one of memory foam, an overmould, and an inflatable tube. In some embodiments, the outer layer may comprise at least one protruding flange portion extending along at least a section of the outer surface of the loop structure. The outer layer may be infused with at least one of a compound, a medicament, a fragrance, and an aromatic agent.
In some embodiments, a film including a compound may be disposed on the loop structure and may be provided with a removable seal to mitigate release of the compound from the film. In some embodiments, a coating is disposed on the loop structure and is arranged to release a scent in response to abrasion of the coating.
Some embodiments relate to a nasal dilator comprising a body for insertion into a nasal cavity of a nose, the body including a loop structure having an inner surface and a reverse outer surface, wherein the inner surface defines an aperture; and an arm member, the arm member extending outwardly from the loop structure; wherein the outer surface of the loop structure is arranged, in use, to urge against a nasal cavity wall in proximity to a nasal vestibule of the nose to allow dilation of the nostril and the arm member is arranged, in use, to extend along the nasal passage and to engage with an internal surface of the nostril.
In some embodiments, the arm member may extend beyond a perimeter of the loop structure and may be configured, in use, to exert an outward force on the internal surface of the nostril to thereby stent and/or dilate the nostril. In some embodiments, in use, the arm member may engage the internal surface of the nostril at a junction of the greater alar cartilage and lateral nasal cartilage to thereby provide improved support for dilation of the nasal passage. In some embodiments, in use, the outer surface of the loop structure urges against the nasal cavity wall to allow the loop structure to concentrically engage with the nasal cavity wall.
Some embodiments relate to a nasal dilator device comprising a first and second nasal dilator as described above, wherein the first and second nasal dilators are coupled together.
Embodiments are described in further detail below, by way of example, with reference to the accompanying drawings, in which:
Described embodiments generally relate to nasal dilators for facilitating respiration. Some embodiments relate to a nasal dilator having a dual dilation mechanism configured to perform dual or concurrent dilation of the nostril of the user. Some embodiments relate to a nasal dilator having a valve mechanism to allow control of inhalation and exhalation through the nose. Some embodiments relate to a nasal dilator having a filtration mechanism to filter airflow during respiration.
Referring to
The inner surface 106 of the loop structure 104 defines an aperture 114. For example, the aperture may be substantially round, teardrop or oval in shape. The outer surface 108 of the loop structure 104 is configured for urging against a nasal passage wall of a nose. For example, in use and as shown in
As illustrated in
In some embodiments, the arm member 116 may be configured to exert an outward force on the internal surface of the nostril of the user to thereby stent and/or dilate the nostril. For example, the arm member 116 may protrude outwardly beyond a perimeter of the loop structure 104 and/or may be resiliently biased to an outward deflecting configuration. In some embodiments, the arm member 116 may be flexible and resiliently biased away from the loop structure 104 to allow the arm member 116 to be compressed for insertion into the nose of a user and to reform once placed inside the nose to thereby dilate the nostrils, as illustrated in
The loop structure 104 and the arm member 116 of the nasal dilator 100 may cooperate as a dual dilation mechanism configured to perform dual or concurrent dilation of the nostril of the user.
Referring to
As illustrated in
Referring now to
As shown in
In some embodiments, for example as depicted in
The pin 404 may be fully or substantially fully inserted into the socket 406 to enable the loop structure 104 to adopt or assume a fully contracted or substantially fully contracted state. The pin 404 may be partially inserted into the socket 406 to enable the loop structure 104 to adopt or assume only a partially contracted state or more dilated state, to provide for greater dilation of the loop structure 104 and to accommodate variations in nasal passage sizes.
Referring to
In some embodiments, as depicted in
The pin 502 may be fully or substantially fully inserted into the socket 504 to enable the loop structure 104 to adopt or assume a fully contracted or substantially fully contracted state. The pin 502 may be partially inserted into the socket 504 to enable the loop structure 104 to adopt or assume only a partially contracted state or more dilated state, to provide for greater dilation of the loop structure 104 and to accommodate variations in nasal passage sizes.
In some embodiments, as depicted in
The belt 602 may be fully or substantially fully inserted into the sleeve 604 to enable the loop structure 104 to adopt or assume a fully contracted or substantially fully contracted state and decreasing the size of the aperture 114. The belt 602 also may be partially inserted into the sleeve 604 to enable the loop structure 104 to adopt or assume only a partially contracted state or more dilated state, to provide for greater dilation of the loop structure 104 and to accommodate variations in nasal passage sizes.
The adjustment mechanism 402 allows the size of the aperture 114 of the loop structure 104 of the nasal dilator 400, 500 and 600 to be adjusted by the user, for example, to provide for a more suitably and comfortable fit prior to insertion. In some embodiments, the adjustment mechanism 402 may be configured to self-adjust during insertion and positioning by the user. For example, with reference to
Referring to
The nasal dilator 700 comprises a platform 702 spanning the aperture 114 defined by the inner surface 106 of the loop structure 104. For example, the platform 702 may comprise a mesh. In some embodiments the platform 702 may be releaseably coupled or attached to the inner surface 106 of the nasal dilator 700, for example by a snap fit or interference fit.
In some embodiments, platform 702 may comprise a filter 704. The filter 704 may be composed of a fine woven mesh or an open celled porous material, such as a foam or compressed fibre. The filter 704 may be employed to filter out airborne particles such as bacteria, dust, pollens, and/or other allergens. In some embodiments, the filter 704 may be replaceable and may be arranged to be removeably connected, or “snap-fit” to the inner surface 106 of the loop structure 104. Alternatively, the filter 704 may be integrally formed with, or may be welded or ultrasonically welded to the loop structure 104.
Referring now to
The nasal dilator 800 comprises a valve mechanism 802 to allow for control of flow of fluid, such as air, through the aperture 114 defined by the inner surface 106 of the loop structure 104. In some embodiments, as depicted in
The seal comprises a flap 806 configured to transition between an open state, whereby fluid, such as air, may be conveyed through the platform 702 and a closed state, whereby fluid, such as air, may be hindered or substantially blocked from being conveyed through the platform 702 by the flap 806. In some embodiments, an orifice 808 may be disposed in the seal 804. In some embodiments, the seal 804, the flap 806 and the platform 702 may be configured to act as a one-way valve, for example, to allow fluid flow, for example, airflow, through the valve mechanism 802 substantially in a single direction only. In some embodiments, the valve mechanism 802 is configured to create a controllable and adjustable positive expiratory air pressure (PEAP) within the nasal cavity. The size of the orifice 808 may be selected to control or at least substantially influence PEAP within the nasal cavity of the nose 304.
Referring now to
The nasal dilator 900 comprises a valve mechanism 902 to allow for control of fluid flow, for example, airflow, through the aperture 114, as defined by the inner surface 106 of the loop structure 104. As depicted in
In some embodiments, an orifice 808 may be disposed in the seal 906. In some embodiments, the ball valve 904, the seal 906 and the platform 702 may be configured to perform as a one-way valve, for example, to allow fluid flow, for example, airflow, through the valve mechanism 902 substantially in a single direction only. In some embodiments, the valve mechanism 902 may create a controllable and adjustable PEAP within the nasal cavity of the nose 304.
By forming a seal with the nasal passage 306, the nasal dilators 700, 800 allow inhalation and exhalation through the nose 304 of the user to be at least somewhat controlled, as well as providing nasal dilation. Thus, the nasal dilators 700, 800 may be employed for treating snoring and obstructive sleep apnea (OSA). For example, OSA is caused by collapse of the nasal passage airway during sleep, which may result in periods of airflow restriction and/or cessation and may contribute to snoring. The nasal dilators 700, 800 make use of the user's own breathing to create positive nasal airway pressure to prevent or mitigate this obstructed breathing by reducing a capacity of the user to exhale through their nose and thereby increasing pressure within the nasal passages. In some embodiments, the nasal dilators 700, 800 allow a user to intake or inhale though the nose 304 while hindering a volume of air exhaled through the nose 304, thereby controlling or at least substantially influencing PEAP.
Referring now to
In some embodiments, as depicted in
In some embodiments, the outer layer 1002 may comprise a deformable material, such as a memory foam or an over mould. The over mould may be infused with a medicament and/or a fragrance. The outer layer 1002 may be formed of a soft elastomeric material, for example. A thickness of the outer layer 1002 may be selected to accommodate a distance between the outer surface 108 of the loop structure 104 and the nasal passage 306 of a user.
Referring now to
As depicted in
Referring now to
As depicted in
Referring now to
Referring now to
Referring now to
In some embodiments, as depicted in
In some embodiments, the arm member 116 of the nasal dilator 1500 comprises a nostril engaging element 1504 having an outwardly facing engagement surface to engage with the nasal passage wall 302 of the nose 304. The nostril engaging element 1504 may comprise a relatively large proportion of the surface area of the arm member 116.
In some embodiments, the nostril engaging element 1504 is provided with a series of protrusions 1506 on the outwardly facing engagement surface. The protrusions 1506 may be composed of a relatively soft over mould material, for example a polymer material such as thermoplastic elastomer (TPE) and/or may be provided as fins or fin-like structures to provide a comfortable and/or grippable surface for engaging with the nasal passage walls 302 of the nose 304. The nostril engaging element 1504 may be substantially oval, rectangular, triangular or truncated triangular in shape. In some embodiments, the protrusions 1506 may form a u-shaped pattern, a v-shaped pattern, or elongated v or ✓ (tick) shaped pattern, such as a chevron design, comprising a plurality of aligned u-shaped, v-shaped or elongated v or ✓ (tick) shaped protrusions 1506.
In some embodiments, the position of the arm member 116 may be adjusted by the user prior to insertion. In some embodiments, the arm member 116 may be configured to self-adjust during insertion and positioning by the user.
Referring now to
The loop structure 104 of nasal dilator 1600 comprises a chamber 1602 arranged to receive a compound, such as a fragrance/aromatic agent or a medicament. The chamber may be positioned in a portion of the loop structure 104 adjacent where the leg member 218 extends from the body 102 or at another suitable location, such as on the arm member 116, for example. The chamber 1602 may be positioned to open outwardly from the outer surface 108 or inwardly from the inner surface 106. The chamber 1602 may be covered or coverable by a removable seal 1604. For example, the seal 1604 may be removed by the user just prior to insertion of the device into the nostril of the user. In this way, the medicament and/or fragrance or aromatic agent is released only when the seal 1604 is removed, thereby increasing a longevity or “shelf-life” and/or protecting the integrity of the medicament and/or aromatic agent. The agent may be an aromatic scent, such as an essential oil blend or synthetic fragrance blend to provide an olfactory and/or physiological response such as decongesting the nasal passage 306, promoting relaxation, promoting sleepiness, suppressing appetite, or a medicament, such as a drug to reduce pain such as a migraine.
Referring now to
As depicted in
In some embodiments, the nasal dilator 100, 200, 400, 500, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1600, 1700 or 1800 may comprise at least one coating or film (not shown) from which a fragrance, aroma or medicament may be released. For example, in some embodiments, the film may be arranged to release a fragrance, aroma or medicament in response to abrasion, such as scratching or scraping. The film may be provided with an outer cover, seal or strip to protect the film from unintended abrasion.
It will be appreciated by persons skilled in the art that numerous variations and/or modifications may be made to the above-described embodiments, without departing from the broad general scope of the present disclosure. The present embodiments are, therefore, to be considered in all respects as illustrative and not restrictive.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/AU2015/050314 | 6/5/2015 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2016/191791 | 12/8/2016 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
851048 | Woodward | Apr 1907 | A |
1034566 | Barratt | Aug 1912 | A |
1077574 | Woodward | Nov 1913 | A |
1255578 | Boxley | Feb 1918 | A |
1481581 | Woodward | Jan 1924 | A |
2243360 | Slatis et al. | May 1941 | A |
3710799 | Caballero | Jan 1973 | A |
3722509 | Nebel | Mar 1973 | A |
3905335 | Kapp | Sep 1975 | A |
4414977 | Rezakhany | Nov 1983 | A |
4576168 | Jalowayski | Mar 1986 | A |
4592357 | Ersek | Jun 1986 | A |
4759365 | Askinazy | Jul 1988 | A |
5059193 | Kuslich | Oct 1991 | A |
5099857 | Baldo et al. | Mar 1992 | A |
5423858 | Bolanos et al. | Jun 1995 | A |
RE35408 | Petruson | Dec 1996 | E |
5683465 | Shinn et al. | Nov 1997 | A |
5693100 | Pisharodi | Dec 1997 | A |
5787884 | Tovey | Aug 1998 | A |
5895409 | Mehdizadeh | Apr 1999 | A |
5931852 | Brennan | Aug 1999 | A |
5955376 | Tovey | Sep 1999 | A |
6109262 | Tovey | Aug 2000 | A |
6129763 | Chauvin et al. | Oct 2000 | A |
6270512 | Rittmann | Aug 2001 | B1 |
6436142 | Paes et al. | Aug 2002 | B1 |
6561188 | Ellis | May 2003 | B1 |
6562057 | Santin | May 2003 | B2 |
6626179 | Pedley | Sep 2003 | B1 |
6821298 | Jackson | Nov 2004 | B1 |
6978781 | Jordan | Dec 2005 | B1 |
7055523 | Brown | Jun 2006 | B1 |
7105008 | Maryanka | Sep 2006 | B2 |
7108198 | Altadonna, Jr. | Sep 2006 | B2 |
7318438 | Brown | Jan 2008 | B2 |
7390331 | Santin et al. | Jun 2008 | B2 |
D575397 | Noce | Aug 2008 | S |
7461651 | Brown | Dec 2008 | B2 |
7727252 | Maryanka | Jun 2010 | B2 |
7740643 | Maryanka | Jun 2010 | B2 |
7918224 | Dolezal et al. | Apr 2011 | B2 |
8048102 | Brown | Nov 2011 | B2 |
D652143 | Brown | Jan 2012 | S |
8262688 | Santin et al. | Sep 2012 | B2 |
8403954 | Santin et al. | Mar 2013 | B2 |
8491622 | Brown | Jul 2013 | B2 |
8834512 | Brown et al. | Sep 2014 | B1 |
D726312 | Johnson | Apr 2015 | S |
D819205 | Snyder | May 2018 | S |
20030081639 | Duan et al. | May 2003 | A1 |
20030086625 | Brennan | May 2003 | A1 |
20030106555 | Tovey | Jun 2003 | A1 |
20030144684 | Ogle | Jul 2003 | A1 |
20040079814 | Altadonne, Jr. | Apr 2004 | A1 |
20040111109 | Ruiz | Jun 2004 | A1 |
20050021073 | Santin et al. | Jan 2005 | A1 |
20050278028 | Mujwid | Dec 2005 | A1 |
20060085027 | Santin et al. | Apr 2006 | A1 |
20060185676 | Brown | Aug 2006 | A1 |
20060185677 | Brown | Aug 2006 | A1 |
20060207598 | Brown | Sep 2006 | A1 |
20060259064 | Maryanka | Nov 2006 | A1 |
20060266367 | Noce | Nov 2006 | A1 |
20070107731 | Reed | May 2007 | A1 |
20070283962 | Doshi et al. | Dec 2007 | A1 |
20080167676 | Howard | Jul 2008 | A1 |
20080178873 | Alpers | Jul 2008 | A1 |
20090145441 | Doshi et al. | Jun 2009 | A1 |
20090194100 | Minagi | Aug 2009 | A1 |
20090198268 | Case | Aug 2009 | A1 |
20100042134 | Wien | Feb 2010 | A1 |
20100063523 | Menard et al. | Mar 2010 | A1 |
20100063532 | Moore | Mar 2010 | A1 |
20100087749 | Tovey | Apr 2010 | A1 |
20110118775 | Brown | May 2011 | A1 |
20120111340 | Robitaille | May 2012 | A1 |
20120279504 | Moore | Nov 2012 | A1 |
20120330345 | Tasca | Dec 2012 | A1 |
20130081637 | Foley | Apr 2013 | A1 |
20130211275 | Curti | Aug 2013 | A1 |
20130296809 | Santin et al. | Nov 2013 | A1 |
20140128904 | Mezzoli et al. | May 2014 | A1 |
20140246023 | Maryanka | Sep 2014 | A1 |
20150000675 | Kallikounis et al. | Jan 2015 | A1 |
20150196420 | Ede et al. | Jul 2015 | A1 |
Number | Date | Country |
---|---|---|
2013204827 | Feb 2014 | AU |
2013205674 | Feb 2014 | AU |
2566268 | Nov 2004 | CA |
101534755 | Sep 2009 | CN |
102970943 | Mar 2013 | CN |
103520815 | Jan 2014 | CN |
203915751 | Nov 2014 | CN |
104619377 | May 2015 | CN |
1917993 | May 2008 | EP |
2387978 | Nov 2011 | EP |
2114326 | Mar 2014 | EP |
1968684 | Feb 2016 | EP |
H11192251 | Jul 1999 | JP |
100893945 | Apr 2009 | KR |
20100096048 | Sep 2010 | KR |
20120020335 | Mar 2012 | KR |
8809149 | Dec 1988 | WO |
9606657 | Mar 1996 | WO |
9607099 | Mar 1996 | WO |
9936773 | Jul 1999 | WO |
0078223 | Dec 2000 | WO |
0162342 | Aug 2001 | WO |
0231465 | Apr 2002 | WO |
02059569 | Aug 2002 | WO |
2004026391 | Apr 2004 | WO |
2007119041 | Oct 2007 | WO |
2008091782 | Jul 2008 | WO |
2008109873 | Sep 2008 | WO |
2009124567 | Oct 2009 | WO |
2011104660 | Sep 2011 | WO |
2012137182 | Oct 2012 | WO |
2014015359 | Jan 2014 | WO |
WO-2014183966 | Nov 2014 | WO |
Entry |
---|
International Search Report in International Application No. PCT/AU2015/050314, dated Aug. 12, 2015, 4 pages. |
Written Opinion of the International Searching Authority in International Application No. PCT/AU2015/050314, dated Aug. 12, 2015, 4 pages. |
International Preliminary Report on Patentability in Int. Appln. No. PCT/AU2016/050621, completed Nov. 21, 2017, 22 pages. |
International Preliminary Report on Patentability in PCT/AU2014/000649, dated Oct. 12, 2016, 5 pages. |
International Preliminary Report on Patentability in PCT/AU2015/050032, dated Dec. 20, 2016, 4 pages. |
International Search Report in Int. Appln. No. PCT/AU2016/050621, dated Oct. 25, 2016, 7 pages. |
International Search Report in PCT/AU2014/000649, dated Sep. 18, 2014, 7 pages. |
International Search Report in PCT/AU2015/050032, dated Apr. 17, 2015, 5 pages. |
Non-Final Office Action in U.S. Appl. No. 15/319,940, dated Apr. 6, 2018, 41 pages. |
Non-Final Office Action in U.S. Appl. No. 15/319,941, dated Apr. 11, 2018, 50 pages. |
Written Opinion of the International Searching Authority in Int. Appln. No. PCT/AU2016/050621, dated Oct. 25, 2016, 7 pages. |
Written Opinion of the International Searching Authority in PCT/AU2014/000649, dated Sep. 18, 2014, 7 pages. |
Written Opinion of the International Searching Authority in PCT/AU2015/050032, dated Apr. 17, 2015, 3 pages. |
Airware Labs, retrieved from the internet Jul. 9, 2018, <URL: https://web.archive.org/web/20120522113321/http://www.airwarelab.com/>, published Mar. 22, 2012, 5 pages. |
Breathe EZ Anti-Snoring Medical Nasal Device—Snoring Cure, retrieved from the internet on Jul. 9, 2018, <URL: https://web.archive.org/web/20120618221246/http://www.snoringcure.ca/breathe_ez_nasal_anti_snoring_medical_device.htm>, published May 14, 2007, 1 page. |
Breathe-Aide, retrieved from the internet Jul. 9, 2018, <URL: https://web.archive.org/web/20141108204923/http://breatheaide.fm.alibaba.com/>, published Nov. 8, 2014, 1 page. |
Breathe-Ezy Nasal Filters, retrieved from the internet Jul. 9, 2018, <URL: https://web.archive.org/web/20120615192635/http://www.breathe-ezy.com.au/>, published Apr. 29, 2005, 6 pages. |
Breathing Relief Nasal Dilator, retrieved from the internet Jul. 9, 2018, <URL: https://web.archive.org/web/20120413210250/http://www.breathingrelief.com/>, published Jun. 16, 2006, 2 pages. |
ClipAir® Anti-Snoring Nasal Dilator Device/Contre le Ronflement, retrieved from the internet on Jul. 9, 2018, <URL: https://web.archive.org/web/20120618061055/http://www.snoringcure.ca/clipair_nasal_anti_snoring_medical_dilator_device.htm>, published Aug. 1, 2010, 2 pages. |
Flents Breathe Quiet! Nasal Dilator—Stop Snoring!, retrieved from the Internet on Jul. 9, 2018, <URL: https://web.archive.org/web/20120425220535/http://www.amazon.com/Flents-Breathe-Quiet-Nasal-Dilator/dp/B0019IHLR2>, published Aug. 29, 2010, 4 pages. |
Flents Breathe Well Nasal Dilator—The Alternative to Nasal Strips, retrieved from the internet Jul. 9, 2018, <URL: https://web.archive.org/web/20120411195907/http://www.amazon.corn/Flents-Breathe-Well-Nasal-Dialator/dp/B001J4K5E2>, published Feb. 2, 2009, 4 pages. |
Inhalclip, retrieved from the internet Jul. 9, 2018, <URL: https://web.archive.org/web/20120413113017/http://www.oscimedsa.com/Stress_insomnie_stop>, published Oct. 21, 2010, 3 pages. |
International Preliminary Examination Report in PCT/AU2003/000504 dated Feb. 2, 2005, 36 pages. |
Max-Air Nose Cones, retrieved from the Internet Jul. 9, 2018, <URL: https://web.archive.org/web/20120725110753/http://www.maxairnosecones.com/max-air-nose-cones>, published Feb. 13, 2011, 8 pages. |
Megavent Nasal Dilator, retrieved from the Internet Jul. 9, 2018, <URL: http://www.wellnessproducts.ch/?lan=en&page=2&id=66999>, published Jun. 26, 2012, 3 pages. |
Nasal Pass Dilator, retrieved from the Internet Jul. 9, 2018, <URL: https://web.archive.org/web/20120630121946/http://nasalpass.com/contact_us.htm>, published Apr. 21, 2006, 1 pages. |
Nasilator, The Science of Better Breathing, retrieved from the Internet Jul. 17, 2018, <URL: https://web.archive.org/web/20121219024329/http://www.nasilator.com/home.aspx>, published Sep. 6, 2012, 1 page. |
Non-Final Office Action in U.S. Appl. No. 10/631,415 dated Aug. 18, 2005, 15 pages. |
Non-Final Office Action in U.S. Appl. No. 10/631,415 dated Dec. 29, 2005, 9 pages. |
Non-Final Office Action in U.S. Appl. No. 11/363,884 dated May 14, 2009, 9 pages. |
Non-Final Office Action in U.S. Appl. No. 11/363,924 dated Apr. 13, 2009, 9 pages. |
Non-Final Office Action in U.S. Appl. No. 12/154,868 dated Oct. 23, 2014, 35 pages. |
Noseglobes, retrieved from the internet Jul. 9, 2018, <URL:https://web.archive.org/web/20110128162352/http://noseglobes.com/>, published Jan. 28, 2011, 1 page. |
Nozovent® Anti-Snoring Medical Nasal Dilator Device, retrieved from the Internet on Jul. 9, 2018, <URL: https://web.archive.org/web/20120619012956/http://www.snoringcure.ca/nozovent_nasal_anti_snoring_medical_dilator_device.htm>, published Jul. 13, 2007, 2 pages. |
Original Breathe Fit Snoring Aid Nasal Dilator, by Breathe Fit Nasal Dilator, retrieved from the internet on Jul. 9, 2018: <URL: https://web.archive.org/web/20120619035547/http://www.amazon.com/Originai-Breathe-Fit-Nasal-Dilator/dp/B0012RMWC4>, published Aug. 21, 2009, 5 pages. |
Sanispira Dpi, retrieved from the internet Jul. 9, 2018, <URL: https://web.archive.org/web/20120712044423/http://www.sanispira.it/eng/index.php>, published Mar. 4, 2011, 3 pages. |
Sinus Cones, retrieved from the Internet Jul. 9, 2018, <URL: https://web.archive.org/web/20120206054639/http://www.sanostec.com/code/productinfo.htm>, published Sep. 8, 2004, 2 pages. |
SleepRight, retrieved from the internet Jul. 11, 2018, <URL: http://www.sleepright.com/nasal-breathe-aid.php, published Jun. 17, 2013, 6 pages. |
Snore Free, retrieved from the internet Jul. 9, 2018, <URL: https://web.archive.org/web/20120614222005/http://www.magnetictherapy.co.uk/scp/SPECIALITY_PRODUCTS/SNORE_FREE.html>, published Dec. 8, 2004, 2 pages. |
Snore Pin, Sleep Apnea Snoring Treatment, retrieved from the Internet Jul. 17, 2018, <URL: https://web.archive.org/web/20130111010828/http://omnisleep.in/snore-pin.html>, published Jan. 11, 2013, 2 pages. |
Snoreben, retrieved from the internet Jul. 9, 2018, <URL: http://www.benmedical.com.au/>, published Jan. 2011, 2 pages. |
Snoregem, British Snoring & Sleep Apnoea Associate, retrieved from the internet Jul. 9, 2018, <URL: https://web.archive.org/web/20120627060249/http://www.britishsnoring.co.uk/shop/snoregem.php>, published Jul. 3, 2010, 2 pages. |
Snore-no-More, retrieved from the internet Jul. 9, 2018, <URL: https://web.archive.org/web/20120626140524/http://www.britishsnoring.co.uk/shop/nasal_dilators/snore_no_more.php?>, published Dec. 12, 2005, 1 pages. |
Surgical Nostril Retainers, Porex Surgical Products Group, retrieved from the internet Jul. 17, 2018, <URL: https://web.archive.org/web/20051217233845/https://www.porexsurgical.com/English/surgical/sprodnoseother.asp>, published Dec. 19, 2005, 2 pages. |
Ultimate Nasal Dilator, retrieved from the internet Jul. 9, 2018, <URL: https://web.archive.org/web/20120718070024/http://www.nasalaid.com/>, published Oct. 28, 2007, 1 page. |
WoodyKnows—Super Nasal Filter for Allergy Relief, retrieved from the internet Jul. 17, 2018, <URL: https://web.archive.org/web/20120818163139/http://www.woodyknows.com:80/>, published Aug. 18, 2012, 3 pages. |
Final Office Action in U.S. Appl. No. 15/319,940 dated Jan. 7, 2020, 25 pages. |
Final Office Action in U.S. Appl. No. 15/319,941 dated Mar. 3, 2020, 41 pages. |
English translation of search report in CN2015800807102 dated Oct. 22, 2020, 2 pages. |
Final Office Action in U.S. Appl. No. 15/319,940, dated May 18, 2021, 12 pages. |
Final Office Action in U.S. Appl. No. 15/319,941, dated May 18, 2021, 13 pages. |
Non-Final Office Action in U.S. Appl. No. 15/748,698, dated Mar. 22, 2021, 26 pages. |
Number | Date | Country | |
---|---|---|---|
20180168846 A1 | Jun 2018 | US |